Clinical Trials Browser

Phase 1/2 × Withdrawn × temsirolimus × Clear all

NCT01335074 2016-11-15

Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular